PUBLISHED DATE : Jul 2023 | Pages : 261
Fill out your details & get your free sample
The U.S. Continuing Medical Education Market Size, Share, & Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028
261 Pages
101 Tables
111 Charts
1 Regions
1 Countries
68 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 4.23 Billion |
| Market Size (2022) | USD 2.91 Billion |
| CAGR (2022-2028) | 6.43% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Delivery Mode, Providers, Providership, and Application |
| Geographic Analysis | United States |
The U.S. continuing medical education market size was valued at USD 2.91 billion in 2022 and is expected to reach USD 4.23 billion by 2028, growing at a CAGR of 6.43% during the forecast period. The market is a rapidly and constantly growing market that offers several lucrative market growth opportunities. Moreover, the revenue growth opportunities for CME providers are increasing the number of physicians. The demand for CME programs significantly increased in COVID-19 patient care delivery and management. But the restriction mandated to reduce the coronavirus infection is a turning point for the U.S. continuing medical education market. The adoption of the e-learning delivery mode approach massively boosts market growth. Millions of healthcare professionals become well-known with online delivery modes for CME activities.
Continuing Medical Education (CME) is a concept that entails continuing education for clinical professionals to enable them to stay abreast of the rapidly evolving practices in the medical field. These learning programs enable health professionals and paraprofessionals at various levels of healthcare delivery systems to update their knowledge and skills. Experts in diverse clinical areas develop, review, and deliver content for a comprehensive range of CME activities through live events, written publications, and online programs. Several market dynamics are shaping the U.S. continuing medical education market landscape. The newly introduced or emerging trends deliver potential factors that show potential for revenue growth for CME providers. Currently, the market landscape is in a rapidly growing phase, and the factors behind rapid growth are rapid evolutions in therapeutic areas, technology adoption and implementation in daily practices, research and development, and rapid advances in the medical education sectors.
Gamification is Advanced Pathway For CME
In continuing medical education (CME), gamification is one trending learning strategy that fulfills the gaps of remote continuing medical education. Also, these platforms do not replace medical education and skills; gamification strategies effectively motivate medical professionals by improving their learning experiences. Health organizations are starting to use and implement video games for healthcare service delivery beyond entertainment. The broad access to chronic diseases management to medication adherence, while healthcare professionals are started using those games to track patient health and medical outcomes in cases from autism to concussion treatments. Further, gamification is growth-delivering potential factors across the U.S. continuing medical education market and offers lucrative growth opportunities. It is a new and effective e-learning CME delivery mode that helps health professionals understand care management and medication adherence. This interactive learning method provides an easy learning pathway for physicians and other healthcare professionals to learn and deliver better patient care.
ChatGPT is the Future of CME
The integration and intervention of next-generation technology in continuing medical education are well-known; however, implementing these technologies is challenging for industries. Although technologies come up with challenges, some upcoming technologies have created huge potential and capacity to transform the U.S. continuing medical education market landscape.
The implementation of Al in medical education opens the door for many new technologies; however, Chatbot (ChatGPT) is one of the emerging technologies that have the potential to accelerate market growth in the US. ChatGPT is an AI-powered chatbot tool that transforms how students and professionals learn and develop new skills. As the CME industry continuously evolves, technologies play a vital role in helping professionals grow and learn. Chatbots can converse with professionals (humans), offering them assistance and information on a broad educational area. ChatGPT is one of the most innovative chatbot tools currently available in the market that has a high potential to completely transform the U.S. continuing medical education market growth.
Mandatory CME Credit Requirements for Healthcare Professionals
Across the U.S., CME credit is mandatory for healthcare professionals, which is the major factor accelerating the U.S. continuing medical education market. The healthcare professionals are segmentized into physicians, allied health professionals, and nurses. Physicians are committed to continuing medical education as part of being active and maintaining licensure. Most U.S. states demand a yearly CME credit quota to maintain an active medical license. In the United States, physicians must complete various modules relating to clinical medicine, medical science, and offering health services and solutions to people.
Medical practitioners maintain or restore patient health by studying, diagnosing, prognosis, and treating diseases, injuries, and other physical and mental impairments. Therefore, educational activities such as CMEs are essential for physicians to maintain, develop, and enhance their professional performance. Several states in the United States require a specified number of credits annually for physicians to remain credentialed to serve their patients and maintain medical licenses. The American Medical Association Physician's Recognition Award authorizes CME credits for physicians in the US. Thus, CME credits are non-negotiable and ongoing requirements throughout the medical career of physicians in the country. However, the CME requirements and licenses are not uniform across different states.
INSIGHTS BY DELIVERY MODE
The U.S. continuing medical education market by delivery mode is segmented into classroom training, e-learning, regularly scheduled series (RSS), journals, and others. In 2022, the classroom training segment accounted for the highest share. Classroom training is considered the most impactful delivery mode to deliver high-quality knowledge, skills, and performance abilities which drive the exponential growth of the segment over other segments. Furthermore, the restrictions implemented during the pandemic by the US government have shifted towards digital continuing medical education, where medical professionals shifted highly towards online CME courses quickly.
INSIGHTS BY PROVIDERS
The U.S. continuing medical education market is segmented by providers into non-profit organizations (NPOs) and physician membership organizations (PMOs), publishing/educational companies, schools of medicine, hospitals and healthcare delivery systems, and others. The NPOs & PMOs segment accounted for a higher market share in 2022. Non-profit organizations & physician membership organizations are leading CME providers in the U.S. due to the hold on accreditation and CME credit delivery. They manage accreditation services to health professionals and others, resulting in substantial segmental growth. The American Association of Continuing Medical Education (ACCME) is one of the leading non-profit organizations headquartered in Chicago, offering many CME programs across the U.S. and several countries worldwide.
INSIGHTS BY PROVIDERSHIP
The U.S. continuing medical education market by providership is segmented into direct and joint providership. The direct providership segment accounted for a higher industry share in 2022. Direct providers are widely present and keep a hold on CME credit accreditation. Whole responsibilities of activities are the major factors that attract more learners to direct providers of CME programs which drive segmental growth. Further, the advantage of direct providership is that they are fully responsible for the accreditation of CME credit. Also, this credit system is valid and offered by only one CME provider, which is self-accredited or accredited by major CME-accredited bodies.
INSIGHTS BY APPLICATION
The U.S. continuing medical education market by application is segmented into oncology, cardiology, infectious disease, orthopedic, dental, primary care, gastroenterology, general surgery, pediatric, allergy & immunology, endocrinology & metabolism, and others. In 2022, the oncology segment accounted for the highest share of over 12% in the U.S. continuing medical education market. Oncology is a rapidly growing therapeutic area across the United States and worldwide. The huge research and development, new medications and treatments constantly evolving resulted in the increasing demand for CME programs by physicians, nurses, and associated allied health professionals who specifically operate for oncology care deliveries and management.
The U.S. continuing medical education market is highly competitive with the presence of types of CME provider vendors. The competitiveness among CME providers is increasing with the rapid evolution in the healthcare industry. In addition, biopharma, medical devices, and other life sciences companies accelerate the high competition among CME providers. Furthermore, there is a significant demand for high-quality and affordable healthcare services across the US. Medical marketing is always evolving, and with unpredictable technological changes, CME providers need to stay on top of new techniques. CME participation has also continued to develop. The healthcare education industry has a high demand for physicians and medical staff, where the supply is scarce. There is an increased demand for high-quality human resources built through a strong academic and learning environment such as CME platforms. Most healthcare providers across the U.S. focus on maintaining a high-quality healthcare system by employing a diverse pool of talented doctors, nurses, and paramedical professionals.
Frequently Asked Questions
How big is the U.S. continuing medical education market?
The U.S. continuing medical education market size was valued at USD 2.91 billion in 2022 and is expected to reach USD 4.23 billion by 2028.
What is the growth rate of the U.S. continuing medical education market?
The U.S. continuing medical education market is growing at a CAGR of 6.43% from 2022-2028.
What are the rising trends in the U.S. continuing medical education market?
The rising trends in the U.S. continuing medical education market are gamification as an advanced pathway for CME, changing CME with digital health systems, increasing involvement of next-generation simulation technology in CME, and chatGPT as the future of CME.
Which application segment holds the most significant U.S. continuing medical education market share?
The oncology application segment dominated the U.S. continuing medical education market share in 2022, accounting for over 12%.
What segments are covered in the U.S. continuing medical education market report?
The segments covered in the U.S. continuing medical education industry report are delivery mode, providers, providership, and application.
The U.S. continuing medical education market size is expected to grow at a CAGR of approximately 6.43% from 2022 to 2028.
The following factors are likely to contribute to the growth of the U.S. continuing medical education market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the U.S. continuing medical education market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Company Profiles
Segmentation by Delivery Mode
Segmentation by Providers
Segmentation by Providership
Segmentation by Application
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY DELIVERY MODE:
4.3.2 MARKET BY PROVIDER
4.3.3 MARKET BY PROVIDERSHIP
4.3.4 MARKET BY APPLICATION
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
6.1.1 US CONTINUING MEDICAL EDUCATION MARKET
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 GAMIFICATION AS ADVANCED PATHWAY FOR CME
9.2 ROLE OF DIGITAL HEALTH SYSTEMS IN TRANSFORMING CME
9.3 INCREASING INVOLVEMENT OF NEXT-GENERATION SIMULATION TECHNOLOGY IN CME
9.4 RESHAPING OF CME WITH CHATGPT
10 MARKET GROWTH ENABLERS
10.1 HIGH PREFERENCE FOR SHORT-TERM CME COURSES
10.2 EMERGENCE OF UNKNOWN AND RARE HEALTH CONDITIONS
10.3 RISE IN MEDICAL SCHOOL ENROLLMENTS & NUMBER OF HEALTHCARE PROFESSIONALS
10.4 MANDATORY CME CREDIT REQUIREMENTS FOR HEALTHCARE PROFESSIONALS
11 MARKET RESTRAINTS
11.1 BIASED CME CONTENT DELIVERY DUE TO INFLUENCE OF BIOPHARMACEUTICAL INDUSTRY
11.2 CHALLENGES ASSOCIATED WITH CME MANAGEMENT
11.3 BARRIERS TO MAINTAINING CME ACCREDITATION
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 MARKET BY DELIVERY MODE: MARKET SHARE ANALYSIS
12.1.2 MARKET BY PROVIDER: MARKET SHARE ANALYSIS
12.1.3 MARKET BY PROVIDERSHIP: MARKET SHARE ANALYSIS
12.1.4 MARKET BY SPECIALTY: MARKET SHARE ANALYSIS
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 DELIVERY MODE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 CLASSROOM TRAINING
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.4 E-LEARNING
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.5 REGULARLY SCHEDULED SERIES (RSS)
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.6 JOURNALS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.7 OTHERS
13.7.1 MARKET OVERVIEW
13.7.2 MARKET SIZE & FORECAST
14 PROVIDER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 NON-PROFIT ORGANIZATIONS (NPOS) & PHYSICIAN MEMBERSHIP ORGANIZATIONS (PMOS)
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 PUBLISHING/EDUCATIONAL COMPANIES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 SCHOOL OF MEDICINE
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.6 HOSPITALS & HEALTHCARE DELIVERY SYSTEMS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.7 OTHERS
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
15 PROVIDERSHIP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 DIRECT PROVIDERSHIP
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.4 JOINT PROVIDERSHIP
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
16 SPECIALTY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 ONCOLOGY
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.4 CARDIOLOGY
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 INFECTIOUS DISEASES
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 ORTHOPEDICS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.7 DENTISTRY
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
16.8 PRIMARY CARE
16.8.1 MARKET OVERVIEW
16.8.2 MARKET SIZE & FORECAST
16.9 GASTROENTEROLOGY
16.9.1 MARKET OVERVIEW
16.9.2 MARKET SIZE & FORECAST
16.10 GENERAL SURGERY
16.10.1 MARKET OVERVIEW
16.10.2 MARKET SIZE & FORECAST
16.11 PEDIATRICS
16.11.1 MARKET OVERVIEW
16.11.2 MARKET SIZE & FORECAST
16.12 ALLERGY & IMMUNOLOGY
16.12.1 MARKET OVERVIEW
16.12.2 MARKET SIZE & FORECAST
16.13 ENDOCRINOLOGY & METABOLISM
16.13.1 MARKET OVERVIEW
16.13.2 MARKET SIZE & FORECAST
16.14 OTHERS
16.14.1 MARKET OVERVIEW
16.14.2 MARKET SIZE & FORECAST
17 COMPETITIVE LANDSCAPE
17.1 COMPETITION OVERVIEW
18 COMPANY PROFILES
18.1 ACADDODLE
18.1.1 BUSINESS OVERVIEW
18.1.2 PRODUCT OFFERINGS
18.2 ACADEMICCME
18.2.1 BUSINESS OVERVIEW
18.2.2 PRODUCT OFFERINGS
18.3 AFFINITYCE
18.3.1 BUSINESS OVERVIEW
18.3.2 PRODUCT OFFERINGS
18.4 ANTIDOTE EDUCATION COMPANY
18.4.1 BUSINESS OVERVIEW
18.4.2 PRODUCT OFFERINGS
18.5 ALBERT EINSTEIN COLLEGE OF MEDICINE
18.5.1 BUSINESS OVERVIEW
18.5.2 PRODUCT OFFERINGS
18.6 AMA EDHUB
18.6.1 BUSINESS OVERVIEW
18.6.2 PRODUCT OFFERINGS
18.7 AMEDCO
18.7.1 BUSINESS OVERVIEW
18.7.2 PRODUCT OFFERINGS
18.8 AMERICAN MEDICAL SEMINARS
18.8.1 BUSINESS OVERVIEW
18.8.2 PRODUCT OFFERINGS
18.9 AO NORTH AMERICA
18.9.1 BUSINESS OVERVIEW
18.9.2 PRODUCT OFFERINGS
18.10 ASPIRUS
18.10.1 BUSINESS OVERVIEW
18.10.2 PRODUCT OFFERINGS
18.11 AXIS MEDICAL EDUCATION
18.11.1 BUSINESS OVERVIEW
18.11.2 PRODUCT OFFERINGS
18.12 AMERICAN COLLEGE OF CARDIOLOGY
18.12.1 BUSINESS OVERVIEW
18.12.2 PRODUCT OFFERINGS
18.13 AMERICAN SOCIETY FOR METABOLIC AND BARIATRIC SURGERY
18.13.1 BUSINESS OVERVIEW
18.13.2 PRODUCT OFFERINGS
18.14 BALLAD HEALTH
18.14.1 BUSINESS OVERVIEW
18.14.2 PRODUCT OFFERINGS
18.15 BAPTISTS HEALTH SOUTH FLORIDA
18.15.1 BUSINESS OVERVIEW
18.15.2 PRODUCT OFFERINGS
18.16 BAYLOR COLLEGE OF MEDICINE
18.16.1 BUSINESS OVERVIEW
18.16.2 PRODUCT OFFERINGS
18.17 BORDERRAC
18.17.1 BUSINESS OVERVIEW
18.17.2 PRODUCT OFFERINGS
18.18 BOSTON UNIVERSITY SCHOOL OF MEDICINE
18.18.1 BUSINESS OVERVIEW
18.18.2 PRODUCT OFFERINGS
18.19 BRODY SCHOOL OF MEDICINE EAST CAROLINA UNIVERSITY
18.19.1 BUSINESS OVERVIEW
18.19.2 PRODUCT OFFERINGS
18.20 BRYAN HEALTH
18.20.1 BUSINESS OVERVIEW
18.20.2 PRODUCT OFFERINGS
18.21 BUREAU OF INFECTIOUS DISEASES AND LABORATORY SCIENCES
18.21.1 BUSINESS OVERVIEW
18.21.2 PRODUCT OFFERINGS
18.22 COPIC INSURANCE COMPANY
18.22.1 BUSINESS OVERVIEW
18.22.2 PRODUCT OFFERINGS
18.23 CURI
18.23.1 BUSINESS OVERVIEW
18.23.2 PRODUCT OFFERINGS
18.24 CME OUTFITTERS
18.24.1 BUSINESS OVERVIEW
18.24.2 PRODUCT OFFERINGS
18.25 CURRENT REVIEWS
18.25.1 BUSINESS OVERVIEW
18.25.2 PRODUCT OFFERINGS
18.26 CARLAT PUBLISHING, LLC AND AFFILIATES
18.26.1 BUSINESS OVERVIEW
18.26.2 PRODUCT OFFERINGS
18.27 CMEPLANET
18.27.1 BUSINESS OVERVIEW
18.27.2 PRODUCT OFFERINGS
18.28 CINE-MED
18.28.1 BUSINESS OVERVIEW
18.28.2 PRODUCT OFFERINGS
18.29 CME PROCEDURES
18.29.1 BUSINESS OVERVIEW
18.29.2 PRODUCT OFFERINGS
18.30 CLINICAL CARE OPTIONS
18.30.1 BUSINESS OVERVIEW
18.30.2 PRODUCT OFFERINGS
18.31 CONTINUING EDUCATION COMPANY
18.31.1 BUSINESS OVERVIEW
18.31.2 PRODUCT OFFERINGS
18.32 EXCEL CME
18.32.1 BUSINESS OVERVIEW
18.32.2 PRODUCT OFFERINGS
18.33 EDCOMPASS
18.33.1 BUSINESS OVERVIEW
18.33.2 PRODUCT OFFERINGS
18.34 EB MEDICINE
18.34.1 BUSINESS OVERVIEW
18.34.2 PRODUCT OFFERINGS
18.35 ESSENTIAL CME
18.35.1 BUSINESS OVERVIEW
18.35.2 PRODUCT OFFERINGS
18.36 FOREFRONT COLLABORATIVE
18.36.1 BUSINESS OVERVIEW
18.36.2 PRODUCT OFFERINGS
18.37 FLORIDA PSYCHIATRIC SOCIETY
18.37.1 BUSINESS OVERVIEW
18.37.2 PRODUCT OFFERINGS
18.38 GA OF THE AMERICAN COLLEGE OF CARDIOLOGY
18.38.1 BUSINESS OVERVIEW
18.38.2 PRODUCT OFFERINGS
18.39 HAYMARKET MEDICAL EDUCATION
18.39.1 BUSINESS OVERVIEW
18.39.2 PRODUCT OFFERINGS
18.40 GREELEY COMPANY
18.40.1 BUSINESS OVERVIEW
18.40.2 PRODUCT OFFERINGS
18.41 GLOBAL EDUCATION GROUP
18.41.1 BUSINESS OVERVIEW
18.41.2 PRODUCT OFFERINGS
18.42 HONORHEALTH
18.42.1 BUSINESS OVERVIEW
18.42.2 PRODUCT OFFERINGS
18.43 HEALTHSTREAM
18.43.1 BUSINESS OVERVIEW
18.43.2 PRODUCT OFFERINGS
18.44 INTELLECTURES
18.44.1 BUSINESS OVERVIEW
18.44.2 PRODUCT OFFERINGS
18.45 INTERNATIONAL ANTIVIRAL SOCIETY-USA
18.45.1 BUSINESS OVERVIEW
18.45.2 PRODUCT OFFERINGS
18.46 KENES GROUP
18.46.1 BUSINESS OVERVIEW
18.46.2 PRODUCT OFFERINGS
18.47 LOWELL GENERAL HOSPITALS
18.47.1 BUSINESS OVERVIEW
18.47.2 PRODUCT OFFERINGS
18.48 MED LEARNING GROUP
18.48.1 BUSINESS OVERVIEW
18.48.2 PRODUCT OFFERINGS
18.49 MEDICUS
18.49.1 BUSINESS OVERVIEW
18.49.2 PRODUCT OFFERINGS
18.50 MAGMUTUAL
18.50.1 BUSINESS OVERVIEW
18.50.2 PRODUCT OFFERINGS
18.51 MED-IQ
18.51.1 BUSINESS OVERVIEW
18.51.2 PRODUCT OFFERINGS
18.52 MEDSCAPE LLC (WEBMED)
18.52.1 BUSINESS OVERVIEW
18.52.2 PRODUCT OFFERINGS
18.53 MIT PROFESSIONALS EDUCATION
18.53.1 BUSINESS OVERVIEW
18.53.2 PRODUCT OFFERINGS
18.54 MLMIC INSURANCE COMPANY
18.54.1 BUSINESS OVERVIEW
18.54.2 PRODUCT OFFERINGS
18.55 NORCAL MUTUAL INSURANCE COMPANY
18.55.1 BUSINESS OVERVIEW
18.55.2 PRODUCT OFFERINGS
18.56 OAKSTONE CME
18.56.1 BUSINESS OVERVIEW
18.56.2 PRODUCT OFFERINGS
18.57 OPUS MEDICUS
18.57.1 BUSINESS OVERVIEW
18.57.2 PRODUCT OFFERINGS
18.58 PROASSURANCE
18.58.1 BUSINESS OVERVIEW
18.58.2 PRODUCT OFFERINGS
18.59 RELIAS LMS
18.59.1 BUSINESS OVERVIEW
18.59.2 PRODUCT OFFERINGS
18.60 STATPEARLS
18.60.1 BUSINESS OVERVIEW
18.60.2 PRODUCT OFFERINGS
18.61 SYANDUS
18.61.1 BUSINESS OVERVIEW
18.61.2 PRODUCT OFFERINGS
18.62 STANFORD MEDICINE
18.62.1 BUSINESS OVERVIEW
18.62.2 PRODUCT OFFERINGS
18.63 THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
18.63.1 BUSINESS OVERVIEW
18.63.2 PRODUCT OFFERINGS
18.64 THE TRUSTEES OF INDIANA UNIVERSITY
18.64.1 BUSINESS OVERVIEW
18.64.2 PRODUCT OFFERINGS
18.65 THE CENTER FOR FORENSIC PSYCHIATRY (CEP)
18.65.1 BUSINESS OVERVIEW
18.65.2 PRODUCT OFFERINGS
18.66 UNIVERSITY OF CALIFORNIA
18.66.1 BUSINESS OVERVIEW
18.66.2 PRODUCT OFFERINGS
18.67 UNIVERSITY OF NORTH DAKOTA
18.67.1 BUSINESS OVERVIEW
18.67.2 PRODUCT OFFERINGS
18.68 THE MEDICAL MUTUAL LIABILITY INSURANCE SOCIETY OF MARYLAND
18.68.1 BUSINESS OVERVIEW
18.68.2 PRODUCT OFFERINGS
19 REPORT SUMMARY
19.1 KEY TAKEAWAYS
19.2 STRATEGIC RECOMMENDATIONS
20 QUANTITATIVE SUMMARY
20.1 MARKET BY DELIVERY MODE
20.2 MARKET BY PROVIDER
20.3 MARKET BY PROVIDERSHIP
20.4 MARKET BY APPLICATION
21 APPENDIX
21.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF THE US CONTINUING MEDICAL EDUCATION MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 US CONTINUING MEDICAL EDUCATION MARKET DYNAMICS
EXHIBIT 4 SEGMENTATION OF US CONTINUING MEDICAL EDUCATION MARKET
EXHIBIT 5 MAJOR BENEFITS OF CME PROGRAMS
EXHIBIT 6 RECOMMENDATIONS FOR DEVELOPMENT OF CME PROGRAMS BY NIH & NICE
EXHIBIT 7 REQUIRED CME CREDITS ANNUALLY FOR PHYSICIANS IN US
EXHIBIT 8 LEADING HEALTH PROFESSIONS & CME CREDIT REQUIREMENTS
EXHIBIT 9 US METROPOLITAN AREAS WITH HIGHEST NUMBER OF REGISTERED NURSES 2023
EXHIBIT 10 IMPACT OF GAMIFICATION AS ADVANCED PATHWAY FOR CME
EXHIBIT 11 GAMIFICATION IN CME AND ASSOCIATED ADVANTAGES
EXHIBIT 12 IMPACT OF ROLE OF DIGITAL HEALTH SYSTEMS IN TRANSFORMING CME
EXHIBIT 13 ALIGNMENT OF LEARNING METHODS & STAGES OF EVIDENCE TRANSLATION
EXHIBIT 14 REASONS FOR HIGH PREFERENCE FOR ONLINE CME PROGRAMS AMONG HEALTHCARE PROFESSIONALS
EXHIBIT 15 IMPACT OF INCREASING INVOLVEMENT OF NEXT-GENERATION SIMULATION TECHNOLOGY IN CME
EXHIBIT 16 INNOVATIVE STRUCTURE OF SIMULATION TECHNOLOGIES IN CME
EXHIBIT 17 IMPACT OF RESHAPING OF CME WITH CHATGPT
EXHIBIT 18 ADVANTAGES OF USING CHATGPT IN CME
EXHIBIT 19 IMPACT OF HIGH PREFERENCE FOR SHORT-TERM CME COURSES
EXHIBIT 20 PREFERENCE FOR CME PROGRAMS BASED ON PHYSICIAN SCHEDULES
EXHIBIT 21 IMPACT OF EMERGENCE OF UNKNOWN AND RARE HEALTH CONDITIONS
EXHIBIT 22 IMPACT OF RISE IN MEDICAL SCHOOL ENROLLMENTS & NUMBER OF HEALTHCARE PROFESSIONALS
EXHIBIT 23 IMPACT OF MANDATORY CME CREDIT REQUIREMENTS FOR HEALTHCARE PROFESSIONALS
EXHIBIT 24 TYPES OF CME CREDITS FOR PHYSICIANS REQUIRED IN THE US
EXHIBIT 25 IMPACT OF BIASED CME CONTENT DELIVERY DUE TO INFLUENCE OF BIOPHARMACEUTICAL INDUSTRY
EXHIBIT 26 IMPACT OF CHALLENGES ASSOCIATED WITH CME MANAGEMENT
EXHIBIT 27 CHALLENGES IN EFFECTIVE MANAGEMENT OF CME
EXHIBIT 28 IMPACT OF BARRIERS TO MAINTAINING CME ACCREDITATION
EXHIBIT 29 CHALLENGES FOR CME ACCREDITATION
EXHIBIT 30 US CONTINUING MEDICAL EDUCATION MARKET BY DELIVERY MODE: MARKET SHARE 2022 & 2028
EXHIBIT 31 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDER: MARKET SHARE 2022 & 2028
EXHIBIT 32 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDERSHIP: MARKET SHARE 2022 & 2028
EXHIBIT 33 US CONTINUING MEDICAL EDUCATION MARKET BY SPECIALTY: MARKET SHARE 2022 & 2028
EXHIBIT 34 US CONTINUING MEDICAL EDUCATION MARKET 2022–2028 ($ BILLION)
EXHIBIT 35 FIVE FORCES ANALYSIS 2022
EXHIBIT 36 INCREMENTAL GROWTH BY SEGMENT 2022 & 2028
EXHIBIT 37 US CONTINUING MEDICAL EDUCATION MARKET BY DELIVERY MODE 2022-2028
EXHIBIT 38 US CONTINUING MEDICAL EDUCATION MARKET BY DELIVERY MODE: SEGMENTAL OVERVIEW
EXHIBIT 39 US CONTINUING MEDICAL EDUCATION MARKET BY DELIVERY MODE: INCREMENTAL GROWTH
EXHIBIT 40 US CONTINUING MEDICAL EDUCATION MARKET BY DELIVERY MODE: ABSOLUTE GROWTH
EXHIBIT 41 EFFECTIVE DELIVERY METHODS FOR CME UNDER CLASSROOM TRAINING
EXHIBIT 42 US CONTINUING MEDICAL EDUCATION MARKET BY CLASSROOM TRAINING: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 43 US CONTINUING MEDICAL EDUCATION MARKET BY CLASSROOM TRAINING 2022–2028 ($ BILLION)
EXHIBIT 44 US CONTINUING MEDICAL EDUCATION MARKET BY E-LEARNING: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 45 US CONTINUING MEDICAL EDUCATION MARKET BY E-LEARNING 2022–2028 ($ BILLION)
EXHIBIT 46 US CONTINUING MEDICAL EDUCATION MARKET BY REGULARLY SCHEDULED SERIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 US CONTINUING MEDICAL EDUCATION MARKET BY REGULARLY SCHEDULED SERIES (RSS) 2022–2028 ($ BILLION)
EXHIBIT 48 MAJOR DEMAND DRIVERS FOR CME JOURNALS
EXHIBIT 49 US CONTINUING MEDICAL EDUCATION MARKET BY JOURNALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 50 US CONTINUING MEDICAL EDUCATION MARKET BY JOURNAL 2022–2028 ($ BILLION)
EXHIBIT 51 EFFECTIVENESS OF MANUSCRIPT REVIEW FOR CME BASED ON 5 DIFFERENT RESOURCES 2020
EXHIBIT 52 US CONTINUING MEDICAL EDUCATION MARKET BY OTHER DELIVERY MODES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 53 US CONTINUING MEDICAL EDUCATION MARKET BY OTHER DELIVERY MODES 2022–2028 ($ BILLION)
EXHIBIT 54 INCREMENTAL GROWTH BY PROVIDERS 2022 & 2028
EXHIBIT 55 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDER 2022-2028
EXHIBIT 56 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDER: SEGMENTAL OVERVIEW
EXHIBIT 57 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDER: INCREMENTAL GROWTH
EXHIBIT 58 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDER: ABSOLUTE GROWTH
EXHIBIT 59 US CONTINUING MEDICAL EDUCATION MARKET BY NPOS & PMOS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 US CONTINUING MEDICAL EDUCATION MARKET BY NPOS & PMOS 2022–2028 ($ BILLION)
EXHIBIT 61 US CONTINUING MEDICAL EDUCATION MARKET BY PUBLISHING/EDUCATIONAL COMPANIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 62 US CONTINUING MEDICAL EDUCATION MARKET PUBLISHING/ EDUCATIONAL COMPANIES 2022–2028 ($ BILLION)
EXHIBIT 63 MAJOR AUDIENCE FOR CME UNDER SCHOOLS OF MEDICINE
EXHIBIT 64 CME INCOME OF SCHOOLS OF MEDICINE ACCREDITED BY ACCME SYSTEM 2021 (%): INCOME BY ORGANIZATION TYPE
EXHIBIT 65 US CONTINUING MEDICAL EDUCATION MARKET BY SCHOOLS OF MEDICINE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 66 US CONTINUING MEDICAL EDUCATION MARKET BY SCHOOLS OF MEDICINE 2022–2028 ($ BILLION)
EXHIBIT 67 ADVANTAGES OF HOSPITAL-BASED CME PROGRAMS
EXHIBIT 68 US CONTINUING MEDICAL EDUCATION MARKET BY HOSPITALS & HEALTHCARE DELIVERY SYSTEMS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 69 US CONTINUING MEDICAL EDUCATION MARKET BY HOSPITALS & HEALTHCARE DELIVERY SYSTEMS 2022–2028 ($ BILLION)
EXHIBIT 70 US CONTINUING MEDICAL EDUCATION MARKET BY OTHER PROVIDERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 71 US CONTINUING MEDICAL EDUCATION MARKET BY OTHER PROVIDERS: 2022–2028 ($ BILLION)
EXHIBIT 72 INCREMENTAL GROWTH BY PROVIDERSHIP 2022 & 2028
EXHIBIT 73 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDERSHIP 2022-2028
EXHIBIT 74 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDERSHIP: SEGMENTAL OVERVIEW
EXHIBIT 75 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDERSHIP: INCREMENTAL GROWTH
EXHIBIT 76 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDERSHIP: ABSOLUTE GROWTH
EXHIBIT 77 US CONTINUING MEDICAL EDUCATION MARKET BY DIRECT PROVIDERSHIP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 78 US CONTINUING MEDICAL EDUCATION MARKET BY DIRECT PROVIDERSHIP 2022–2028 ($ BILLION)
EXHIBIT 79 US CONTINUING MEDICAL EDUCATION MARKET BY JOINT PROVIDERSHIP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 80 US CONTINUING MEDICAL EDUCATION MARKET BY JOINT PROVIDERSHIP 2022–2028 ($ BILLION)
EXHIBIT 81 INCREMENTAL GROWTH BY SPECIALTY 2022 & 2028
EXHIBIT 82 US CONTINUING MEDICAL EDUCATION MARKET BY SPECIALTY 2022-2028
EXHIBIT 83 US CONTINUING MEDICAL EDUCATION MARKET BY SPECIALTY: SEGMENTAL OVERVIEW
EXHIBIT 84 US CONTINUING MEDICAL EDUCATION MARKET BY SPECIALTY: SEGMENTAL OVERVIEW
EXHIBIT 85 US CONTINUING MEDICAL EDUCATION MARKET BY SPECIALTY: INCREMENTAL GROWTH
EXHIBIT 86 US CONTINUING MEDICAL EDUCATION MARKET BY ONCOLOGY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 87 US CONTINUING MEDICAL EDUCATION MARKET BY ONCOLOGY 2022–2028 ($ BILLION)
EXHIBIT 88 US CONTINUING MEDICAL EDUCATION MARKET BY CARDIOLOGY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 89 US CONTINUING MEDICAL EDUCATION MARKET BY CARDIOLOGY 2022–2028 ($ BILLION)
EXHIBIT 90 US CONTINUING MEDICAL EDUCATION MARKET BY INFECTIOUS DISEASES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 91 US CONTINUING MEDICAL EDUCATION MARKET BY INFECTIOUS DISEASES 2022–2028 ($ BILLION)
EXHIBIT 92 ADVANTAGES OF ORTHOPEDIC CME PROGRAMS
EXHIBIT 93 US CONTINUING MEDICAL EDUCATION MARKET BY ORTHOPEDICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 94 US CONTINUING MEDICAL EDUCATION MARKET BY ORTHOPEDICS 2022–2028 ($ BILLION)
EXHIBIT 95 US CONTINUING MEDICAL EDUCATION MARKET BY DENTISTRY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 96 US CONTINUING MEDICAL EDUCATION MARKET BY DENTISTRY 2022–2028 ($ BILLION)
EXHIBIT 97 US CONTINUING MEDICAL EDUCATION MARKET BY PRIMARY CARE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 98 US CONTINUING MEDICAL EDUCATION MARKET BY PRIMARY CARE 2022–2028 ($ BILLION)
EXHIBIT 99 US CONTINUING MEDICAL EDUCATION MARKET BY GASTROENTEROLOGY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 100 US CONTINUING MEDICAL EDUCATION MARKET BY GASTROENTEROLOGY 2022–2028 ($ BILLION)
EXHIBIT 101 US CONTINUING MEDICAL EDUCATION MARKET BY GENERAL SURGERY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 102 US CONTINUING MEDICAL EDUCATION MARKET BY GENERAL SURGERY 2022–2028 ($ BILLION)
EXHIBIT 103 US CONTINUING MEDICAL EDUCATION MARKET BY PEDIATRICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 104 US CONTINUING MEDICAL EDUCATION MARKET BY PEDIATRICS 2022–2028 ($ BILLION)
EXHIBIT 105 US CONTINUING MEDICAL EDUCATION MARKET BY ALLERGY & IMMUNOLOGY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 106 US CONTINUING MEDICAL EDUCATION MARKET BY ALLERGY & IMMUNOLOGY 2022–2028 ($ BILLION)
EXHIBIT 107 US CONTINUING MEDICAL EDUCATION MARKET BY ENDOCRINOLOGY & METABOLISM: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 108 US CONTINUING MEDICAL EDUCATION MARKET BY ENDOCRINOLOGY & METABOLISM 2022–2028 ($ BILLION)
EXHIBIT 109 US CONTINUING MEDICAL EDUCATION MARKET BY OTHER SPECIALTIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 110 US CONTINUING MEDICAL EDUCATION MARKET BY OTHER SPECIALTIES 2022–2028 ($ BILLION)
EXHIBIT 111 NUMBER OF CME PROVIDERS IN US & RATE OF ACTIVITIES COMPARED TO PREVIOUS YEAR
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2022
TABLE 3 HEALTHCARE WORKERS STATISTICS IN US 2020
TABLE 4 STATES IN US WITH HIGHEST NUMBER OF PHYSICIANS & THEIR CME CREDIT REQUIREMENTS
TABLE 5 POPULAR ALLIED HEALTH PROFESSIONALS & THEIR CE REQUIREMENTS IN US
TABLE 6 CURRENT DEVELOPMENT IN CME WITH GAMIFICATION
TABLE 7 MEDICAL ENROLLMENT DETAILS IN US 2021–2022
TABLE 8 CME REQUIREMENTS FOR PHYSICIANS IN US BY STATES 2023 (LEADING STATES WITH HIGH NUMBER OF PHYSICIANS)
TABLE 9 CLASSROOM TRAINING CME PRESENTED BY PROVIDERS ACCREDITED IN THE ACCME SYSTEMS 2021
TABLE 10 TYPES OF REGULARLY SCHEDULES SERIES
TABLE 11 CME PRESENTED BY REGULARLY SCHEDULED SERIES ACCREDITED IN ACCME SYSTEM 2022
TABLE 12 REGULARLY SCHEDULED SERIES CME BY PROVIDERS ACCREDITED IN ACCME SYSTEM
TABLE 13 JOURNAL-BASED CME PRESENTED BY PROVIDERS IN ACCME SYSTEMS 2021
TABLE 14 ENDURING MATERIAL CME BY PROVIDERS ACCREDITED IN ACCME SYSTEM
TABLE 15 ACCME ACTIVITIES OFFERED BY NPOS & PMOS 2021
TABLE 16 LEADING NPOS OFFERING CME PROGRAMS IN US
TABLE 17 SOME MAJOR PHYSICIAN MEMBERSHIP ORGANIZATIONS IN US
TABLE 18 OTHER CME PRESENTED BY PROVIDERS ACCREDITED IN THE ACCME SYSTEM 2021 (TOTAL REPORTED INCOME)
TABLE 19 CME PRESENTED BY ACCME ACCREDITED PROVIDERS 2021 (TOTAL PROVIDERS 640)
TABLE 20 MAJOR DIRECT CME PROVIDERS ACCREDITED WITH ACCME IN US
TABLE 21 JOINTLY ACCREDITED CME PROVIDERS IN US
TABLE 22 OPPORTUNITIES FOR CARDIOLOGY CME IN US
TABLE 23 STATISTICS OF DENTISTS IN US 2022
TABLE 24 OTHER MEDICAL SPECIALTIES WITH MANDATORY CME CREDITS FOR PHYSICIANS IN US
TABLE 25 CME ACTIVITIES PRESENTED PROVIDERS ACCREDITED IN ACCME SYSTEMS (REVISED NOVEMBER 2022)
TABLE 26 ACADOODLE: MAJOR PRODUCT OFFERINGS
TABLE 27 ACADEMICCME: MAJOR PRODUCT OFFERINGS
TABLE 28 AFFINITYCE: MAJOR PRODUCT OFFERINGS
TABLE 29 ANTIDOTE EDUCATION COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 30 ALBERT EINSTEIN COLLEGE OF MEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 31 AMA EDHUB: MAJOR PRODUCT OFFERINGS
TABLE 32 AMEDCO: MAJOR PRODUCT OFFERINGS
TABLE 33 AMERICAN MEDICAL SEMINAR: MAJOR PRODUCT OFFERINGS
TABLE 34 AO NORTH AMERICA: MAJOR PRODUCT OFFERINGS
TABLE 35 ASPIRUS: MAJOR PRODUCT OFFERINGS
TABLE 36 AXIS MEDICAL EDUCATION: MAJOR PRODUCT OFFERINGS
TABLE 37 AMERICAN COLLEGE OF CARDIOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 38 AMERICAN SOCIETY FOR METABOLIC AND BARIATRIC SURGERY: MAJOR PRODUCT OFFERINGS
TABLE 39 BALLAD HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 40 BAPTIST HEALTH SOUTH FLORIDA: MAJOR PRODUCT OFFERINGS
TABLE 41 BAYLOR COLLEGE OF MEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 42 BORDERRAC: MAJOR PRODUCT OFFERINGS
TABLE 43 BOSTON UNIVERSITY SCHOOL OF MEDICINE (BUSM): MAJOR PRODUCT OFFERINGS
TABLE 44 BRODY SCHOOL OF MEDICINE EAST CAROLINA UNIVERSITY: MAJOR PRODUCT OFFERINGS
TABLE 45 BRYAN HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 46 BUREAU OF INFECTIOUS DISEASE AND LABORATORY SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 47 COPIC INSURANCE COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 48 CURI: MAJOR PRODUCT OFFERINGS
TABLE 49 CME OUTFITTERS: MAJOR PRODUCT OFFERINGS
TABLE 50 CURRENT REVIEWS: MAJOR PRODUCT OFFERINGS
TABLE 51 CARLAT PUBLISHING, LLC AND AFFILIATES: MAJOR PRODUCT OFFERINGS
TABLE 52 CME PLANET: MAJOR PRODUCT OFFERINGS
TABLE 53 CINE-MED: MAJOR PRODUCT OFFERINGS
TABLE 54 CME PROCEDURES: MAJOR PRODUCT OFFERINGS
TABLE 55 CLINICAL CARE OPTIONS: MAJOR PRODUCT OFFERINGS
TABLE 56 CONTINUING EDUCATION COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 57 EXEL CME: MAJOR PRODUCT OFFERINGS
TABLE 58 EDCOMPASS: MAJOR PRODUCT OFFERINGS
TABLE 59 EB MEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 60 ESSENTIAL CME: MAJOR PRODUCT OFFERINGS
TABLE 61 FOREFRONT COLLABORATIVE: MAJOR PRODUCT OFFERINGS
TABLE 62 FLORIDA PSYCHIATRIC SOCIETY: MAJOR PRODUCT OFFERINGS
TABLE 63 GA CHAPTER OF THE AMERICAN COLLEGE OF CARDIOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 64 HAYMARKET MEDICAL EDUCATION: MAJOR PRODUCT OFFERINGS
TABLE 65 GREELEY COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 66 GLOBAL EDUCATION GROUP: MAJOR PRODUCT OFFERINGS
TABLE 67 HONORHEALTH: MAJOR PRODUCT OFFERINGS
TABLE 68 HEALTHSREAM: MAJOR PRODUCT OFFERINGS
TABLE 69 INTELLECTURES: MAJOR PRODUCT OFFERINGS
TABLE 70 INTERNATIONAL ANTIVIRAL SOCIETY-USA: MAJOR PRODUCT OFFERINGS
TABLE 71 KENES GROUP: MAJOR PRODUCT OFFERINGS
TABLE 72 LOWELL GENERAL HOSPITAL: MAJOR PRODUCT OFFERINGS
TABLE 73 MED LEARNING GROUP: MAJOR PRODUCT OFFERINGS
TABLE 74 MEDICUS: MAJOR PRODUCT OFFERINGS
TABLE 75 MAGMUTUAL: MAJOR PRODUCT OFFERINGS
TABLE 76 MED-IQ: MAJOR PRODUCT OFFERINGS
TABLE 77 MEDSCAPE LLC. (WEBMD): MAJOR PRODUCT OFFERINGS
TABLE 78 MIT PROFESSIONAL EDUCATION: MAJOR PRODUCT OFFERINGS
TABLE 79 MLMIC INSURANCE COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 80 NORCAL MUTUAL INSURANCE COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 81 OAKSTONE CME: MAJOR PRODUCT OFFERINGS
TABLE 82 OPUS MEDICUS: MAJOR PRODUCT OFFERINGS
TABLE 83 PROASSURANCE: MAJOR PRODUCT OFFERINGS
TABLE 84 RELIAS LMS: MAJOR PRODUCT OFFERINGS
TABLE 85 STATPEARLS: MAJOR PRODUCT OFFERINGS
TABLE 86 SYANDUS: MAJOR PRODUCT OFFERINGS
TABLE 87 STANFORD MEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 88 THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS: MAJOR PRODUCT OFFERINGS
TABLE 89 THE INDIANA UNIVERSITY SCHOOL OF MEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 90 THE CENTER FOR FORENSIC PSYCHIATRY: MAJOR PRODUCT OFFERINGS
TABLE 91 UNIVERSITY OF CALIFORNIA (IRVINE): MAJOR PRODUCT OFFERINGS
TABLE 92 UNIVERSITY OF NORTH DAKOTA: MAJOR PRODUCT OFFERINGS
TABLE 93 THE MEDICAL MUTUAL LIABILITY INSURANCE SOCIETY OF MARYLAND: MAJOR PRODUCT OFFERINGS
TABLE 94 US CONTINUING MEDICAL EDUCATION MARKET BY DELIVERY MODE 2022–2028 ($ BILLION)
TABLE 95 US CONTINUING MEDICAL EDUCATION MARKET BY DELIVERY MODE 2022–2028 (%)
TABLE 96 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDER 2022–2028 ($ BILLION)
TABLE 97 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDER 2022–2028 (%)
TABLE 98 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDERSHIP 2022–2028 ($ BILLION)
TABLE 99 US CONTINUING MEDICAL EDUCATION MARKET BY PROVIDERSHIP 2022–2028 (%)
TABLE 100 US CONTINUING MEDICAL EDUCATION MARKET BY APPLICATION 2022–2028 ($ BILLION)
TABLE 101 US CONTINUING MEDICAL EDUCATION MARKET BY APPLICATION 2022–2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
